Showing posts with label e-cigarette risks. Show all posts
Showing posts with label e-cigarette risks. Show all posts

Thursday, August 31, 2023

Say Goodbye to the American Lung Association

 

While the American Lung Association bills itself as “the leading organization working to save lives by improving lung health and preventing lung disease,” the group’s recent formal comment on the FDA Center for Tobacco Products’ Strategic Plan essentially endorses the greatest threat to lung health: cigarette manufacturers. Here is an excerpt from the group’s filing:

“Strategic Goal #4 - Improve Public Health by Enhancing Knowledge and Understanding of CTP Tobacco Product Regulation and the Risks Associated with Tobacco Product Use 

Remove language from the description for this goal that references informing adults about the relative risk of tobacco products” (emphasis in original)

“As mentioned in our comments above, the description for this goal included language ‘and to inform adults who smoke about the relative risks of tobacco products.’ The Lung Association strongly recommends this language be removed from the description.”

The ALA asks the FDA to remove any reference to the scientific fact that smoke-free tobacco products are vastly safer than cigarettes.  They are effectively urging the agency to withhold lifesaving information about safer products from smokers and their loved ones.

The nonprofit world’s poor record on cigarettes led me eight years ago to advise the public to say goodbye to the American Cancer Society.  Still, the American Lung Association in 2020 reported revenue of $106 million, with some 60% attributable to fundraising events, gifts and other contributions. 

It’s time for tobacco users and their families and friends to defund the cigarette-manufacturer-supporting American Lung Association.  Send your charitable contributions elsewhere. 

 

 


  

 

Wednesday, April 6, 2022

Why Do High Schoolers Vape? National Youth Tobacco Surveys Suggest Answers

 

 

 

Federal officials blame vape manufacturers and retailers for teen vaping, focusing in particular on the industry’s use of flavoring, but government surveys indicate the truth is more nuanced.

The government’s National Youth Tobacco Surveys (NYTS) routinely collect information on teenage e-cigarette use.  I examined survey data for the years when vaping accelerated (2018 and 2019), and when it declined (2020 and 2021).  In the first three years, the survey asked, “What are the reasons that you have used e-cigarettes?”  In 2021, the question changed to, “Why do you currently use e-cigarettes?”  Other survey modifications occurred, as noted in the Table footnotes.

 

High School Vapers: Percentage Reporting Why They Have Used [Currently Use*] E-cigarettes, NYTS 2018-2021





Reason2018201920202021





Used by friend30%*21%*37%27%
Used by family member

86
To quit other tobacco11984
Costs less than other tobacco6634
Easier to get than other tobacco6655
Used by people on TV, online, movies1432
Less harmful than other tobacco25181410
Flavors36232013
Use unnoticed8181714
Other reason30182519
Peer pressure---8------
Used to do tricks---232419
Curious---48429
Use when anxious, stressed, depressed---------42
Nicotine buzz---------44
 
*Friend and family member combined
--  Reason not asked
Participants could choose multiple reasons

 

Let’s look at some of the bigger trends.  First, among reasons measured in all four years, “friends’ use” is consistently the most important, which jibes with the common observation that most teens obtain e-cigarettes from friends rather than retail stores.  “Other” reasons ranks second, followed by “flavors”, “less harmful”, and “use unnoticed at home or school”.  Note that the percentage of respondents mentioning flavors fell from 36% in 2018, to 13% in 2021, undercutting activist arguments to ban them.  The percentage mentioning less harmful also declined, from 25% to 10%, likely reflecting the success of the FDA’s grossly misleading “Real Cost” campaign that asserts that e-cigarettes are equally or more harmful than cigarettes.

Additional reasons for vaping, offered in NYTS after 2018, were also selected at high rates; these included “performing tricks” and “curiosity”.  In 2021, 42% of vapers said they vaped because they were anxious, stressed or depressed, and 44% were trying to get a nicotine buzz.

Also of note: “Quitting other products”, “costing less”, “easier to get”, and “celebrities” were not frequently cited as important reasons to vape. 

Why, one might ask, was there so much variation across the four years?  The answer may well lie with the inherent variability of self-reporting by teenage respondents.

 

Tuesday, October 19, 2021

More Bad Behavior from Journal Authors & Editors on A Fatally Flawed Study of Vaping & COPD


Following is another example of junk science published by anti-tobacco crusaders, abetted by negligent journal editors.

The journal Tobacco Induced Diseases on April 7 published an article by Emine Bircan and colleagues at the University of Arkansas.  They claimed that e-cigarette use “is associated with increased odds of self-reported asthma, COPD, and [asthma-COPD overlap syndrome] among never combustible cigarette smokers.” In their abstract, the authors assert that “the age of those at risk in our study was 18–24 years.” 

First, take a look at the chart.  It is axiomatic that COPD is mostly seen in current and former smokers age 55+ years.  Now look at Bircan’s vapers in the last column: the distribution is completely upside down! This led me to examine the article in greater detail, whereupon I discovered numerous obvious errors.

Since the journal prohibits submissions from industry-funded scientists (my research is supported by unrestricted grants to the University of Louisville from tobacco companies), the only avenue to attempt to correct the errors was to write the authors directly.  I exchanged numerous emails with corresponding author Mohammed Orloff and journal editor James Scott over the period April 22 – May 12. Copies of this correspondence are available here.

In addition to raising the issue of young adults with COPD, I listed these significant errors:

1. There were two obvious wrong numbers of never cigarette smokers.

2. The inaccurate and non-standard term “e-cigarette smokers” was used throughout the article.

3. The authors referred to a question (“Do you still have COPD?”) that did not appear in the analyzed surveys.

4. The authors reversed two numbers in a flow chart describing important exclusions.

5. The authors failed to define “missing variables”.

These egregious errors should have been discovered and corrected by the authors, and by the journal’s reviewers and editors. Among the five authors is Pebbles Fagan, Ph.D., a former member of the FDA Tobacco Products Scientific Advisory Committee.

Dr. Orloff responded to my letter: “I should say I feel very embarrassed. Indeed this was sloppy on our side and we will fix and connect with the Editors in Chief on how to move forward.”

Still, the mess wasn’t immediately resolved. I downloaded the datasets from the U.S. government’s Behavioral Risk Factor Surveillance System (BRFSS).  But I was unable to reproduce the article’s study groups, the first basic step of any serious review. When Dr. Orloff disclosed further details of the analysis, I discovered that the authors had deleted 27,000 participants from the BRFSS data who had “ever” used an e-cigarette – even just one time – but did not use them at all at the time of the survey. This critical deletion was made without mention or explanation anywhere in the article. I advised Dr. Orloff that this large cohort should be classified as non-users of e-cigarettes, and the analysis should be re-run.

Dr. Orloff ended the correspondence shortly thereafter, around May 12.

Fast forward to the week of October 12, when the journal published a completely new version of the article, accompanied by the following statement: “The authors would like to express their apologies and regret for the errors in the original published version of the abovementioned article. The corrected article follows.”

The authors corrected their obvious errors, but failed to correct or add any reference to the 27,000 excluded ever vapers. Instead, they added the following brand new text to the discussion section to explain it away, as if it had been part of their research plan:

“Additionally, participants who reported having used e-cigarettes in their lifetime and currently do not use e-cigarettes (defined as former e-cigarette users) were excluded from the study population because of lack of clarity of exposure status and residual effects that have resulted from the e-cigarette derived chemical exposure which contribute to changes in the continuum of the disease progression leading to molecular changes detectable by biomarker analysis rather than reports. These former e-cigarette users have used e-cigarettes sometime in their entire life and have quit for different reasons. Studies have shown that while cessation of tobacco use diminishes the risk of experiencing long-term adverse health effects, past history of tobacco use is still associated with increased risk of lung diseases compared to never having smoked [citation here to a 1997 article ‘Smoking, alcohol consumption, and leukocyte counts.’]”

This explanation makes no sense. It is not valid to define someone who ever used an e-cigarette – even one time -- as a former user. The authors, post-hoc, unsuccessfully defended tossing out 27,000 ever vapers by inventing a “chemical exposure…leading to molecular changes… sometime in their entire life.”  But they kept in their study people who smoked up to 100 cigarettes – a far more toxic product. 

While Tobacco Induced Diseases inappropriately deleted the original article from their website, it is still available at the U.S. National Library of Medicine (here). I have also placed a copy of that original work here.

If the authors had adhered to professional standards, they would have acknowledged my major contributions in their corrective comments, but they did not.

I subsequently learned that Riccardo Polosa, a University of Catania (Italy) physician specializing in respiratory diseases, submitted a letter to the editor of Tobacco Induced Diseases, strongly questioning the validity of respiratory diseases in 18- to 24-year-old e-cigarette users. His letter was rejected.